STRATEGIA is a strategic marketing consultancy, specialized in providing decision support for biopharmaceutical products in early development (from late pre-clinical stages through to the end of phase 2).

their pipeline assets; and
products they're evaluating for in- or out-licensing.
Our mission is to ensure that our clients optimize the value of their pipeline assets, and maximize returns for investors. To deliver on our mission, we have developed a strategic framework called Differentiation by Design©.
The molecule is what it is, but how you develop it matters!
Strategic support to optimize the value of your pipeline
STRATEGIA BioPharma Consulting GmbH
Contact: info@strategia.co
UID:  CHE-438.252.546 HR/MWST

Strategic decisions made early in a new biopharma product's development determine its value:
Selecting the right indication for launch;
Segmenting the patient population;
Developing a differentiated, value-based TPP; and
Guiding clinical development strategy.
Strategy is about making choices - about what to do, and what not to do right now.

We partner with our clients to assist them in making an informed decision about development strategy, to optimize the balance between risk and return with: